Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

In 2018, two young men were found dead in their respective bathrooms in Texas after using a concentrated powder form of tianeptine.  Tianeptine is an antidepressant prescribed in Europe, Asia and South America. It’s banned in the US, but it’s found its way here. The Food and Drug Administration (FDA) issued a warning about the drug’s risks in 2018. Then in February 2022, the agency put out a new warning after scientists found a large increase in calls to poison control centers related to tianeptine poisoning. What is Tianeptine? Tianeptine, sold under the brand names of Coaxil and Stablon, is…

Read More

If you watch television, you’ve likely seen the commercials for the JAK (Janus kinase) inhibitors Xeljanz and Rinvoq that make bold claims. Those ads depict men and women ziplining, moving large amounts of heavy soil, hauling furniture and riding ATVs. “The [misleading] message is that you don’t have to be limited in any way,” explains Terry Graedon, PhD, a medical anthropologist and co-host of The People’s Pharmacy. “I would say that the likelihood [is pretty slim] that this is a realistic goal for most people, much less women with rheumatoid arthritis,  especially if they are people whose condition has not…

Read More
FDA

When Matthew Feshbach, then an investor, first heard about a California company developing treatments for a variety of diseases using stem cells derived from a patient’s own fat cells (autologous adipose-derived cells), he thought, That’s the biggest idea I’ve ever heard.

Read More

MedShadow is introducing a weekly news feature called Quick Hits: brief summaries of recent news items related to our mission. Light therapy is under investigation as a way to ease the fatigue and depression that people with cancer often suffer from. Researchers at the Icahn School of Medicine at Mount Sinai in New York City conducted a series of clinical trials examining whether regular exposure to bright white light from a light box could improve their symptoms. In the latest trial, cancer patients exposed to the bright white light saw their depression symptoms subside much more than a control group…

Read More